WuxiAppTec raised HK$7.70 billion (US$981 million) in a sale of additional shares to fund its global expansion.

Major players such as Sun Pharma, Dr. Reddy’s Laboratories, Cipla, Divi’s Laboratories, Aurobindo Pharma, Lupin, and Biocon faced market volatility.

A federal judge has blocked a new Arkansas law that would have prohibited pharmacy benefit managers, or PBMs—middlemen companies who set drug prices—from owning ...

Catch all live updates on Indian stock markets here on July 31. Stocks are set to react to Donald Trump's 25% tariff on India.

Pharmexcil Chairman warns of US drug shortages and price hikes due to tariffs on Indian pharmaceutical imports.

Trump's 25% tariff on Indian goods will increase essential drug prices in the US, impacting consumers and healthcare. India ...

Merck & Co., Inc. (NYSE:MRK) is one of the most undervalued blue chip stocks to buy according to hedge funds. On July 21, Oppenheimer analyst Ken Wong noted that Outperform-rated Veeva announced that ...

License agreement supports Madrigal's pipeline strategy to develop innovative combination treatments for MASH, anchored by its foundational therapy Rezdiffra (resmetirom) Combining Rezdiffra with the ...

Already, the pharmaceutical sector accounts for nearly seven per cent of Manitoba’s GDP. Pfizer, Bausch Health and Dynacare ...

A federal judge has temporarily blocked an Arkansas law that would have banned pharmacy benefit managers from owning ...

A former General Motors exec joins Ford to run its commercial fleet division. She will expand its revenue opportunities in ...

Fort Myers-based NeoGenomics reported mixed results for the second quarter. Revenue grew 10% over the year, but the net loss ...